Literature DB >> 7671555

Ionophoretic activity of meglitinide analogues.

A Bakkali-Nadi1, F Malaisse-Lagae, W J Malaisse.   

Abstract

The sodium and calcium ionophoretic activity of meglitinide and three of its hypoglycemic analogs, namely S3075, KAD-1229 and repaglinide was examined in an artificial membrane model. All agents were able to cause the translocation of 45Ca and 22Na from an aqueous solution into an immiscible organic phase. The results were compatible with the formation of a calcium-ionophore complex with a 1-2 stoichiometry. The ionophoretic activity ranged in the following hierarchy: KAD-1229 > S3075 > repaglinide = meglitinide and, hence, did not closely parallel the insulinotropic potential of these non-sulfonylurea hypoglycemic agents. It is proposed, therefore, that the ionophoretic capacity of meglitinide analogs may not represent an essential determinant of their insulin-releasing action.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7671555

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  4 in total

Review 1.  The role of sulphonylureas in the management of type 2 diabetes mellitus.

Authors:  Marc Rendell
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.

Authors:  Lisa Kitasato; Taiki Tojo; Yuko Hatakeyama; Ryo Kameda; Takehiro Hashikata; Minako Yamaoka-Tojo
Journal:  Cardiovasc Diabetol       Date:  2012-06-29       Impact factor: 9.951

3.  Long-term Effects of Mitiglinide in Japanese Diabetics Inadequately Controlled with DPP-4 Inhibitor or Biguanide Monotherapy.

Authors:  Kohei Kaku; Nobuya Inagaki; Naoki Kobayashi
Journal:  Diabetes Ther       Date:  2014-02-01       Impact factor: 2.945

4.  Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus.

Authors:  Young Min Cho; Bo Kyung Koo; Ho Young Son; Kwang Woo Lee; Hyun Shik Son; Dong Seop Choi; Bo Wan Kim; Yong Ki Kim; Moon Kyu Lee; Hyun Chul Lee; Kyung Wan Min; Min Young Chung; Hong Sun Baek; Youngkun Kim; Hyung Joon Yoo; Kyong Soo Park; Hong Kyu Lee
Journal:  J Diabetes Investig       Date:  2010-08-02       Impact factor: 4.232

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.